Inlägg av Admin medac

BCG – leverancesituation

Opdatering: 2019-08-30. BCG-medac er på nuværende tidspunkt ikke tilgængeligt. Vi forventer en mindre leverance i uge 35, og herefter næste leverance i uge 40. Vi opdaterer information om leverancesituationen kontinuerligt.

Medac app NMIBC Toolbox

NMIBC Toolbox er en 2-trins interaktiv hjælp til brug af EAU’s guidelines for ikke-muskelinvasiv blærekræft. 1) Det giver brugeren mulighed for at identificere risikoklassen for overfladiske blære tumorer med 6 diagnostiske faktorer, defineret i EAU retningslinjerne. 2) Den forbinder og viser kirurgiske og konservative installations regimer, som er anbefalet til den tilsvarende tumor risikoklasse af […]

Lomustine forbedrer overlevelsen for glioblastompatienter med metyleret MGMT promotor

Et studie anført af Prof. Herrlingen i Bonn, som blev præsenteret på 2017-mødet for Society for NeuroOncology, er nu publiceret i ”The Lancet”. „Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3” (Lancet 2019;393:678-88) Dette studie kan anses som en milepæl, […]

Medac has received the Yellow Hand Award

Medac received the Yellow Hand Award for the second consecutive time during the European Conference Oncology Pharmacy. The Yellow Hand Award is given by ESOP, European Society of Oncology Pharmacy. The Yellow Hand Award is awarded to companies who ensure safe transportation and handling of cystostatics throughout the complete supply chain and was first given in […]

Press release – Alacare®

Innovative therapeutic for the treatment of mild actinic keratoses – first self-adhesive patch for PDT The skin lesion actinic keratosis is associated with an estimated prevalence of up to 60 % in certain populations and bears a high disease burden being considered as precancerous The treatment option with the ALA-PDT patch has not only been […]

Press release

medac passes eco-audit and receives award for environmental management medac Gesellschaft für klinische Spezialpräparate mbH is innovative, successful, sustainable and environment-friendly. The pharmaceutical company has proven that economic prosperity and environmental responsibility are not necessarily a contradiction. To achieve perfect conditions for this objective, medac subjected itself to an auditing procedure according to EMAS and […]